Lung Function Impairment and Metabolic Syndrome The Critical Role of Abdominal Obesity

被引:384
作者
Leone, Nathalie [1 ]
Courbon, Dominique [1 ]
Thomas, Frederique [2 ]
Bean, Kathy [2 ]
Jego, Bertrand [2 ]
Leynaert, Benedicte [1 ]
Guize, Louis [2 ]
Zureik, Mahmoud [1 ]
机构
[1] Univ Paris 07, INSERM, Fac Med Xavier Bichat, U700, F-75018 Paris, France
[2] Invest Prevent & Clin, Paris, France
关键词
lung function tests; metabolic syndrome; abdominal fat; principal component analysis; epidemiologic studies; C-REACTIVE PROTEIN; OBSTRUCTIVE PULMONARY-DISEASE; FORCED VITAL CAPACITY; BODY-FAT DISTRIBUTION; 3RD NATIONAL-HEALTH; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; ASSOCIATION; RISK;
D O I
10.1164/rccm.200807-1195OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Increased risk for cardiovascular morbidity and mortality has been related to both lung function impairment and metabolic syndrome. Data on the relationship between lung function and metabolic syndrome are sparse. Objectives: To investigate risk for lung function impairment according to metabolic syndrome traits. Methods: This cross-sectional population-based study included 121,965 men and women examined at the Paris Investigations Preventives et Cliniques Center between 1999 and 2006. The lower limit of normal was used to define lung function impairment (FEV1 or FVC < lower limit of normal). Metabolic syndrome was assessed according to the American Heart Association/National Heart, Lung, and Blood Institute statement. Measurements and Main Results: We used a logistic regression model and principal component analysis to investigate the differential associations between lung function impairment and specific components of metabolic syndrome. Lung function impairment was associated with metabolic syndrome (prevalence = 15.0%) independently of age, sex, smoking status, alcohol consumption, educational level, body mass index, leisure-time physical activity, and cardiovascular disease history (odds ratio [OR] [95% confidence interval], 1.28 [1.20-1.37] and OR, 1.41 [1.31-1.51] for FEV1 and FVC, respectively). Three factors were identified from factor analysis: "lipids" (low high-density lipoprotein cholesterol, high triglycerides), "glucose-blood pressure" (high fasting glycemia, high blood pressure), and "abdominal obesity" (large waist circumference). All factors were inversely related to lung function, but abdominal obesity was the strongest predictor of lung function impairment (OR, 1.94 [1.80-2.09] and OR, 2.11 [1.95-2.29], for FEV1 and FVC, respectively). Similar results were obtained for women and men. Conclusions: We found a positive independent relationship between lung function impairment and metabolic syndrome in both sexes, predominantly due to abdominal obesity. Further studies are required to clarify the underlying mechanisms.
引用
收藏
页码:509 / 516
页数:8
相关论文
共 60 条
  • [21] The metabolic syndrome in smokers. The DESIR study
    Geslain-Biquez, C
    Vol, S
    Tichet, J
    Caradec, A
    D'Hour, A
    Balkau, B
    [J]. DIABETES & METABOLISM, 2003, 29 (03) : 226 - 234
  • [22] Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
    Grundy, SM
    Cleeman, JI
    Daniels, SR
    Donato, KA
    Eckel, RH
    Franklin, BA
    Gordon, DJ
    Krauss, RM
    Savage, PJ
    Smith, SC
    Spertus, JA
    Costa, F
    [J]. CIRCULATION, 2005, 112 (17) : 2735 - 2752
  • [23] All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions
    Guize, Louis
    Thomas, Frederique
    Pannier, Bruno
    Bean, Kathy
    Jego, Bertrand
    Benetos, Athanase
    [J]. DIABETES CARE, 2007, 30 (09) : 2381 - 2387
  • [24] Components of the "metabolic syndrome" and incidence of type 2 diabetes
    Hanson, RL
    Imperatore, G
    Bennett, PH
    Knowler, WC
    [J]. DIABETES, 2002, 51 (10) : 3120 - 3127
  • [25] The effect of gender on the relationship between body fat distribution and lung function
    Harik-Khan, RI
    Wise, RA
    Fleg, JL
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2001, 54 (04) : 399 - 406
  • [26] Hole DJ, 1996, BRIT MED J, V313, P711
  • [27] The metabolic syndrome: Time for a critical appraisal - Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
    Kahn, R
    Buse, J
    Ferrannini, E
    Stern, M
    [J]. DIABETES CARE, 2005, 28 (09) : 2289 - 2304
  • [28] Waist circumference and cardiometabolic risk - A consensus statement from shaping America's health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; The American Society for Nutrition; And the American Diabetes Association
    Klein, Samuel
    Allison, David B.
    Heymsfield, Steven B.
    Kelley, David E.
    Leibel, Rudolph L.
    Nonas, Cathy
    Kahn, Richard
    [J]. DIABETES CARE, 2007, 30 (06) : 1647 - 1652
  • [29] The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
    Lakka, HM
    Laaksonen, DE
    Lakka, TA
    Niskanen, LK
    Kumpusalo, E
    Tuomilehto, J
    Salonen, JT
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (21): : 2709 - 2716
  • [30] LANGE P, 1990, EUR RESPIR J, V3, P288